Evidence map›Paper›PMID 28530638›Full record

ArticleThe Journal of clinical investigation2017

Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability.

Jianying Huang, Carlos G Vanoye, Alison Cutts, Y Paul Goldberg, Sulayman D Dib-Hajj, Charles J Cohen, Stephen G Waxman, Alfred L George

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of clinical investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Functional and molecular diversity of human C-fibers in pain modulation.Current opinion in supportive and palliative care · 2026
    Review
  3. Review
  4. Targeting NaInternational journal of molecular sciences · 2026
    Review
  5. Shaping the Action Potential in Dorsal Root and Trigeminal Ganglia Neurons: Relevance to Pain Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Nav1.8, an analgesic target for nonpsychotomimetic phytocannabinoids.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Article
  16. Review
  17. Peripheral temperature dysregulation associated with functionally altered NaPflugers Archiv : European journal of physiology · 2023
    Article
  18. NaExperimental neurology · 2023
    Article
  19. Article
  20. A TRPM7 mutation linked to familial trigeminal neuralgia: Omega current and hyperexcitability of trigeminal ganglion neurons.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jianying HuangDepartment of Neurology and Center for Neuroscience and Regeneration Research, Yale University School of Medicine; and Rehabilitation Research Center, Veterans Administration Connecticut Healthcare System, West Haven, Connecticut, USA.
Carlos G VanoyeDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Alison CuttsXenon Pharmaceuticals, Burnaby, British Columbia, Canada.
Y Paul GoldbergXenon Pharmaceuticals, Burnaby, British Columbia, Canada.
Sulayman D Dib-HajjDepartment of Neurology and Center for Neuroscience and Regeneration Research, Yale University School of Medicine; and Rehabilitation Research Center, Veterans Administration Connecticut Healthcare System, West Haven, Connecticut, USA.
Charles J CohenXenon Pharmaceuticals, Burnaby, British Columbia, Canada.
Stephen G WaxmanDepartment of Neurology and Center for Neuroscience and Regeneration Research, Yale University School of Medicine; and Rehabilitation Research Center, Veterans Administration Connecticut Healthcare System, West Haven, Connecticut, USA.
Alfred L GeorgeDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Center for Neuroscience and Regenerative Medicine · USXenon Pharmaceuticals (Canada) · CANorthwestern University · US

Funding

HEREDITARY DEFECTS IN HUMAN SODIUM CHANNELSR01NS032387 · NINDS · VANDERBILT UNIVERSITY · PI GEORGE, ALFRED L. · 1994 to 2015
$3.2M
Hereditary Defects in Human Sodium ChannelsR37NS032387 · NINDS · VANDERBILT UNIVERSITY · PI GEORGE, ALFRED L. · 2003 to 2009
$2.6M
NINDS NIH HHS R01 NS032387NINDS NIH HHS R37 NS032387
6 · The paper itself

Abstract

Voltage-gated sodium channel (NaV) mutations cause genetic pain disorders that range from severe paroxysmal pain to a congenital inability to sense pain. Previous studies on NaV1.7 and NaV1.8 established clear relationships between perturbations in channel function and divergent clinical phenotypes. By contrast, studies of NaV1.9 mutations have not revealed a clear relationship of channel dysfunction with the associated and contrasting clinical phenotypes. Here, we have elucidated the functional consequences of a NaV1.9 mutation (L1302F) that is associated with insensitivity to pain. We investigated the effects of L1302F and a previously reported mutation (L811P) on neuronal excitability. In transfected heterologous cells, the L1302F mutation caused a large hyperpolarizing shift in the voltage-dependence of activation, leading to substantially enhanced overlap between activation and steady-state inactivation relationships. In transfected small rat dorsal root ganglion neurons, expression of L1302F and L811P evoked large depolarizations of the resting membrane potential and impaired action potential generation. Therefore, our findings implicate a cellular loss of function as the basis for impaired pain sensation. We further demonstrated that a U-shaped relationship between the resting potential and the neuronal action potential threshold explains why NaV1.9 mutations that evoke small degrees of membrane depolarization cause hyperexcitability and familial episodic pain disorder or painful neuropathy, while mutations evoking larger membrane depolarizations cause hypoexcitability and insensitivity to pain.

Indexed as

Mutation, MissensePain Insensitivity, CongenitalAction PotentialsAdultAmino Acid SubstitutionFemaleHumansIon Channel GatingNAV1.9 Voltage-Gated Sodium ChannelNeuronsNAV1.9 Voltage-Gated Sodium ChannelSCN11A protein, human

Identifiers

PMID28530638
PMCPMC5490760
OpenAlexW2616644093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.